Search results
Xponance Inc. Sells 939 Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
ETF DAILY NEWS· 18 hours agoXponance Inc. reduced its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 6.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Expected to Post Q1 2024 Earnings of ($0.83) Per Share
ETF DAILY NEWS· 7 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Research analysts at Wedbush raised their Q1 2024 earnings per share estimates for Apellis Pharmaceuticals in a note issued to investors ...
Mirae Asset Global Investments Co. Ltd. Reduces Holdings in REGENXBIO Inc. (NASDAQ:RGNX)
ETF DAILY NEWS· 6 days agoMirae Asset Global Investments Co. Ltd. trimmed its position in shares of REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 54.7% in the 4th quarter, according to its most recent disclosure with ...
Wedbush Weighs in on Apellis Pharmaceuticals, Inc.’s FY2025 Earnings (NASDAQ:APLS)
ETF DAILY NEWS· 7 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush dropped their FY2025 EPS estimates for Apellis Pharmaceuticals in a report released on Wednesday, April ...
Apellis Pharmaceuticals, Inc. Expected to Earn Q2 2025 Earnings of $0.23 Per Share (NASDAQ:APLS)
ETF DAILY NEWS· 3 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Zacks Research upped their Q2 2025 EPS estimates for Apellis Pharmaceuticals in a report issued on Tuesday, April 23rd. Zacks Research ...